|
|
|
PRESS RELEASE: Pharmaceutical Compliance Forum's Fourteenth Pharmaceutical Regulatory Compliance Congress Features Chief Compliance Officer Roundtable
|
- Sponsored by the Pharmaceutical Compliance Forum
- October 28 - 30, 2013
- Onsite at Hyatt Regency on Capitol Hill, Washington, DC
- Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com
|
SPONSORED BY:
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.
|
|
|
FEATURING CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
 |
Eve Costopoulos, Esq., Vice President, Chief Ethics and Compliance Officer, Eisai Inc., Woodcliff Lake, NJ
|
 |
Alessandra Hawthorne, Esq., Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim Pharmaceuticals, Inc., New York, NY
|
 |
Michael L. Shaw, Esq., Vice President and Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, Philadelphia, PA
|
 |
Caroline West, Esq., Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.; Former Vice President, Global Legal Compliance, Aventis, Philadelphia, PA
|
 |
Thomas M. Gallagher, Esq., Partner and Chair, White Collar and Corporate Investigations Practice Group, Pepper Hamilton LLP, Philadelphia, PA (Moderator)
|
|
|
|
WASHINGTON DC USA -- CME UPDATE NEWS SERVICE™ -- AUGUST 20, 2013: The Fourteenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (the Pharma Congress), www.PharmaCongress.com, will take place on October 28-30, 2013 at the Hyatt Regency on Capitol Hill in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
|
KEYNOTE SPEAKERS
|
Thomas W. Abrams, RPh, MBA
Director, Division of Drug Marketing, Advertising, and Communications, Center for Drug Evaluation and Research CDER), Food and Drug Administration, Silver Spring, MD |
Andrew M. Dahlem, PhD
Vice President, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN |
Mark Glickman, MBA
Executive Vice President, Sales and Marketing, Auxilium Pharmaceuticals; Former Vice President-Medical Device Division, Otsuka America Pharmaceutical, Inc.; Former Senior Vice President Sales and Marketing, Oscient Pharmaceuticals, New York, NY
|
Dominique Laymand, Esq.
Vice President Compliance & Ethics EMEA, (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, President, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Paris, France |
Zane David Memeger, Esq.
United States Attorney, Eastern District of Pennsylvania, Philadelphia, PA |
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, Department of Health and Human Services, Washington, DC
|
Brent L. Saunders, JD, MBA
Chief Executive Officer, Bausch + Lomb, Former President of Global Consumer Health Care and Former Senior Vice President, Global Compliance and Business Practices , Schering-Plough, Rochester, NY |
Arun Sharma, MBA, PhD
Professor and Executive Director, JAE Leadership Institute, School of Business Administration, University of Miami, Miami, FL |
Mit Spears, Esq.
Executive Vice President and General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA), Former General Counsel, Federal Trade Commission, Former Principal Deputy Assistant Attorney General, Civil and Environmental and Natural Resources Divisions, United States Department of Justice, Washington, DC
|
|
|
|
CHIEF COMPLIANCE OFFICERS ROUNDTABLE
|
Eve Costopoulos, Esq.
Vice President, Chief Ethics & Compliance Officer, Eisai Inc., Woodcliff Lake, NJ |
Alessandra Hawthorne, Esq.
Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim Pharmaceuticals, Inc., New York, NY |
Michael L. Shaw, Esq.
Vice President and Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, Philadelphia, PA
|
Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.; Former Vice President, Global Legal Compliance, Aventis, Philadelphia, PA |
Thomas M. Gallagher, Esq.
Partner and Chair, White Collar and Corporate, Investigations Practice Group, Pepper Hamilton LLP, Philadelphia, PA (Moderator)
|
|
|
|
AUSA ROUNDTABLE
|
Margaret (Peg) Hutchinson, Esq.
Assistant US Attorney and Chief, Civil Division, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA |
Paul Kaufman, Esq.
Assistant US Attorney Chief of Civil Healthcare Fraud, United States Attorney's Office, Eastern District of New York, Brooklyn, NY |
Richard Robinson, Esq. (Invited)
Section Chief-Major Frauds, Criminal Division, United States Attorney's Office, Central District of California, Los Angeles, CA
|
Susan Winkler, Esq. (Invited)
Assistant US Attorney and Chief, Health, Care Fraud Unit, United States Attorney's Office, District of Massachusetts, Boston, MA |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC (Moderator)
|
|
|
|
LESSONS LEARNED FROM PUBLIC SERVICE
|
Nathaniel B. Edmonds, Esq.
Partner, Paul Hastings, Former Assistant Chief, Foreign Corrupt Practices Act Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
Lewis Morris, Esq.
Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD
|
Vivian Robinson, Esq.
QC, Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court; Former Treasurer of Inner Temple, London, UK |
Kathleen Meriwether, Esq.
Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP; Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA (Moderator)
|
|
|
|
FEATURING PRECONFERENCE SESSIONS
|
- Compliance Basics
- Auditing and Monitoring Boot Camp
- Ethical Decision Making Workshop
- Chief Compliance Officer (or designee) Summit (Invitation Only)
|
|
|
|
PLENARY SESSIONS
|
- Chief Compliance Officer Roundtable
- Interactive Dialogue on Compliance Issues via Discussion and Audience Response System
- AUSA Roundtable
- Keynote: OIG Update
- Keynote: FDA-OPDP Update
- Keynote: PhRMA Update
- Keynote: Pharma Compliance: A Global Business Perspective
- Views from the C-suite: The Role of Compliance in HR, R&D and Sales & Marketing
- State Disclosure Laws, Federal Sunshine Act and Global Transparency Initiatives
- Lessons Learned from Public Service
|
|
POSTCONFERENCE SESSION
|
- Compliance as a Strategic Function
|
|
PHARMA CONGRESS IS
|
|
|
|
|
AND THE FOLLOWING MINI SUMMITS
|
- Adult Learning and Leading as a Compliance Professional
- Anticorruption Update, Including FCPA and UK Bribery Act
- Handling Parallel Criminal, Civil and Administrative Investigations
- Sunshine in Depth
- How to Grow a Chief Compliance Officer
- Managing Third Party Relationship Risks
- Government Pricing Update
- Changes to the Commercial Business Model: Defining & Measuring Value to the Patient
- OIG Increases Auditing of Pharmaceutical Manufacturers
- Fair Market Value Update
- Compliance in Commercial Operations Update
- Off-label Promotion: Will the Government Take the First Amendment Seriously?
- Life Sciences Privacy and Data Protection Issues Update
- Ethics and Compliance: Laughter is Still the Best Medicine
- The Interplay between Company Culture and Compliance
- Changes to the Commercial Business Model: Defining the Customer & Influencer
- Emerging Pharma Compliance Issues in the Technology Space
- Update on Data Sharing/Data Transparency in Clinical Trials
- How to Build a Robust and Sustainable Compliance Organization
- Medical Device Compliance Issues Update
- HCP Compliance re On-label vs. Off-label Marketing
- Blowing the Whistle on cGMPs: The Next Big Challenge for Compliance
- Global Compliance Update
- Changes to the Commercial Business Model: New Landscape of Disruptive Technology & Big Data
|
|
|
WHISTLEBLOWERS AND WHISTLEBLOWERS COUNSEL AND ADVISORS
|
Cheryl Eckard
Plaintiff/relator U.S. ex rel. Eckard v. GSK, et al., Former Senior Manager of Global Quality Assurance, Glaxo SmithKline, New York, NY |
Neil V. Getnick, Esq.
Managing Partner, Getnick & Getnick LLP, New York, NY
|
Luis Moreno-Ocampo, Esq.
Former First Chief Prosecutor, International Criminal Court; Former President, Latin America and Caribbean Office, Transparency International, New York, NY |
Lesley Ann Skillen, Esq.
Partner, Getnick & Getnick LLP, New York, NY
|
|
|
|
LEADING COMPANY COMPLIANCE PROFESSIONALS AND COUNSEL
|
Leslie Altizer
Director, Corporate Executive Board, Director, Compliance and Ethics Leadership Council, Arlington, VA |
Gregory W. Beeman
Ethics and Compliance Officer, Lilly USA, Eli Lilly and Company, Indianapolis, IN |
Barbara E. Bierer, MD
Senior Vice President Research, Brigham and Women's Hospital, Professor of Medicine and Pediatrics, Harvard Medical School, Faculty Co-Chair, Multi-Regional Clinical Trials Center, Harvard University (Harvard MRCT), Boston, MA
|
Damon Burrows, Esq.
Vice President and Assistant General Counsel - Regulatory, Allergan; Former Senior Counsel, Roche Pharmaceuticals, Irvine, CA |
Katherine Chaurette, Esq.
Senior Corporate Counsel, Healthcare, Sanofi, Wayne, PA |
Thomas E. Costa
Vice President, US Pharmaceuticals Compliance, Bristol-Myers Squibb, Princeton, NJ
|
Gina Dunsmuir
Health Care Compliance Officer, Ortho Clinical Diagnostics, Inc., Red Bank, NJ |
Steven N. Gersten, Esq.
Divisional Vice President, Ethics and Compliance Officer, International and Global Marketing, Abbvie, Chicago, IL |
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY
|
Jeffrey Klimaski, MBA, CPA
Compliance Officer, BTG International, Former Vice President, Global Compliance Officer, Stiefel, a GSK company Philadelphia, PA |
Maxine Nogard, MBA
Senior Director, Corporate Compliance, Biogen Idec, Inc., Weston, MA |
Katherine Norris
Compliance Consultant, The Spectranetics Corporation, Atlanta, GA
|
Josh O'Harra, Esq.
Assistant General Counsel, Eli Lilly and Company, Washington DC |
Caroline Stockwell
Assistant General Counsel, R&D, Pfizer; Solicitor (England and Wales), Walton on the Hill, Surrey, United Kingdom
|
Stephanie Wisdo, Esq.
Corporate Counsel, Otsuka Pharmaceuticals, Rockville, MD |
Christopher D. Zalesky
Executive Director, World Wide Office of Health Care Compliance and Privacy, Johnson & Johnson, New Brunswick, NJ
|
|
|
|
AND TRUSTED CONSULTANTS AND COUNSEL
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France |
Leslie Altizer
Director, Corporate Executive Board, Director, Compliance and Ethics Leadership Council, Arlington, VA |
Yogesh Bahl, MBA
Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY
|
Mark Barnes, Esq.
Partner, Ropes and Gray LLP; Faculty Co-Chair, Multi-Regional Clinical Trials Center, Harvard University (Harvard MRCT); Former Senior Associate Provost for Research and Chief University Research Compliance Officer, Harvard University, Boston, MA |
Mary Bennett
Vice President Advisory Services, Ethical Leadership Group™, The Advisory Services Practice of NAVEX Global, Former Vice President of the Compliance, and Integrity Group, Caremark, Mundelein, IL |
Chris Bergstrom, MBA
Chief Strategy and Commercial Officer, WellDOC, Baltimore, MD
|
Diane E. Bieri, Esq.
Partner, FDA and Healthcare and Antitrust Practice Groups, Arnold & Porter, Washington, DC |
Jeffrey S. Bucholtz, Esq.
Partner, King & Spalding LLP, Former Acting Assistant Attorney General, Civil Division, US Department of Justice, Washington, DC |
Jan Byars, PhD
Founder and President, LeadSync, LLC, Co-Chair, Ethics Forum Learning Community, Vandalia, OH
|
Stephen Celestini, Esq.
Consultant, Aquinas Leadership Group; Former Senior Vice President, Chief Compliance Officer, Inspire Pharmaceuticals, a subsidiary of Merck, Inc., Raleigh, NC |
Scott A. Coffina, Esq.
Partner, Drinker Biddle & Reath LLP, Former Associate Counsel to President George W. Bush, Former Assistant US Attorney, Philadelphia, PA |
Kris Curry
Principle, Fraud Investigation and Dispute Services, Ernst & Young LLP, Former Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson, Philadelphia, PA
|
Mark A. DeWyngaert, PhD
Managing Director, Huron Consulting Group, New York, NY |
Kip Ebel, MBA
Partner, Ernst & Young, New York, NY |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
|
Todd Evans
Director, PricewaterhouseCoopers LLP, Pharmaceutical & Life Sciences Advisory, Chicago, IL |
Ronnie Feldman, MBA
Director, Second City Communications, Chicago, IL |
Wain Fishburn, Jr., Esq.
Partner, Cooley, LLP, San Diego, CA
|
Wendy C. Goldstein, Esq.
Partner, Health Care & Life Sciences Regulatory Practice, Cooley, LLP, New York, NY |
Ames Gross, MBA
President and Founder, Pacific Bridge Medical, Bethesda, MD |
Peter Harries, MBA
Partner, Health Information & Privacy Advisory, PricewaterhouseCoopers LLP, Los Angeles, CA
|
Brian L. Hengesbaugh, Esq.
Partner and Global Co-Leader, Privacy and Data Protection Practice, Baker & McKenzie LLP, Chicago, IL |
Michael Hercz, Esq.
Director, Audit and Enterprise Risk Services, Deloitte & Touche LLP; Former Vice President and Chief Compliance Officer, Victory Pharmaceuticals, Inc., Costa Mesa, CA |
Paul E. Kalb, JD, MD
Partner and Global Coordinator, Life Sciences Practice, Sidley Austin LLP, Washington, DC
|
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC |
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC
|
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman, Morristown, NJ |
Joshua Pagliaro
Director, PricewaterhouseCoopers LLP, Pharmaceutical & Life Sciences Advisory, Chicago, IL |
Jeremy Perisho
Partner and National Life Sciences & Health Care Industry Leader, Deloitte Financial Advisory Services LLP, Boston, MA
|
Donna Phelps
Product Specialist, Advisory Service, Navex Global, Former Senior Director of Corporate Compliance, Biogen Idec, Lake Oswega, OR |
John Poulin
Director, Huron Consulting Group, New York, NY |
Paula J. Presnoples, MPA, SPHR
Consultant, LeadSync, LLC, Vandalia, OH
|
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC |
Retta M. Riordan, JD
President, Riordan Compliance LLC, Former Business Ethics and Compliance Officer, Organon Biosciences, Research Trial Area, NC |
Janet L. "Lucy" Rose
President, Lucy Rose and Associates, LLC, Former Director, DDMAC, FDA, Washington, DC
|
William A. Sarraille, Esq.
Partner, Sidley Austin LLP, Washington, DC |
Mark Scallon
Partner, Polaris, San Francisco, CA |
Paul J. Silver
Managing Director, Huron Consulting Group, Atlanta, GA
|
Don Soong
Vice President of Strategic Solutions, Cegedim Relationship Management, Richmond, VA |
Larry Spears
Director, Life Sciences Regulatory, Governance, Regulatory and Risk Strategies, Deloitte & Touche LLP, Washington, DC |
Jack T. Tanselle
Director, Healthcare Dispute Compliance, and Investigation Practice, Navigant Consulting, Inc., Indianapolis, IN
|
Seth Whitelaw, JD, LLM, SJD
Director, Life Sciences Regulatory Compliance Practice, Deloitte & Touche LLP, Former R&D Compliance Officer, GlaxoSmithKline, Former Legal, Compliance Officer, SmithKline Beecham Pharmaceuticals, Philadelphia, PA |
Brian Williams
Director, PwC, Pharmaceutical and Life Sciences Advisory Services, Indianapolis, IN |
Ronald L. Wisor, Jr., Esq.
Partner, Hogan Lovells US LLP, Washington, DC
|
Matthew Yesko, CPLP
Senior Consultant, Aquinas Leadership Group, Raleigh-Durham, NC |
Richard L. Zimmerer
Partner, Forensic Advisory Services, KPMG LLP, Los Angeles, CA
|
|
|
|
|
|
EARLY BIRD REGISTRATION
- SAVE $400 -
|
Register by Friday, September 13, 2013 for Early Bird discount and save up to $400.
Click here to register.
|
|
CO CHAIRS
|
Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb Company, Plainsboro, NJ
|
Margaret K. Feltz, Esq.
Director, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
Kelly B. Freeman, PhD
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN
|
Elizabeth V. Jobes, Esq.
Senior Vice President, Chief Compliance Officer, Auxilium Pharmaceuticals Inc., Philadelphia, PA
|
|
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS:
|
|
|
PCF PHARMA CONGRESS PLANNING COMMITTEE
|
Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb Company (Co chair)
Margaret K. Feltz
Director, Corporate Compliance, Purdue Pharma LP (Co chair)
Kelly B. Freeman, PhD
Senior Director, Ethics and Compliance, Eli Lilly and Company (Co chair)
Elizabeth V. Jobes, Esq.
Senior Vice President, Chief Compliance Officer, Auxilium Pharmaceuticals Inc. (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP
Karen Anderson
Chief Compliance Officer, Cubist Pharmaceuticals Inc.
Timothy Ayers, Esq.
Compliance Consulting
Wayne Baker
Senior Vice President and Chief Sales Officer, AHM
Valli Baldassano
President and CEO, VFB Associates, PC
Scott Bass, Esq.
Partner, Sidley Austin LLP
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP
Eve M. Brunts, Esq.
Partner, Ropes & Gray
Eve Costopoulos
Vice President, Chief Ethics & Compliance Officer, Eisai Inc.
Sujata T. Dayal
Corporate Vice President and Chief Compliance Officer, Global Operations, Biomet, Inc.
Michael B. Dusseau
Divisional Compliance Officer, Merck Consumer Care
Keary Dunn, Esq.
Global Head, Ethics and Compliance, Novartis Oncology
Sue Egan
Director and Principal Consultant, Sue Egan Associates
Thomas Forrester, Esq.
Vice President, US Legal Affairs and General Counsel, Lundbeck Inc.
Thomas M. Gallagher, Esq.
Partner and Chair, White Collar and Corporate Investigations Practice Group, Pepper Hamilton LLP
Steven N. Gersten, Esq.
Vice President and Ethics & Compliance Officer, AbbVie
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.
Wendy C. Goldstein, Esq.
Partner, Cooley, LLP
Alessandra N. Hawthorne
Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim USA, Inc.
Michael Hercz, Esq.
Director, Audit and Enterprise Risk Services, Deloitte & Touche LLP
Jonathon Kellerman
Partner, Pharmaceutical & Life Sciences Advisory Services, PricewaterhouseCoopers LLP
Daniel Kracov, Esq.
Partner, Arnold & Porter LLP
Maxine Nogard
Senior Director, Global Corporate Compliance, Biogen Idec, Inc.
John Patrick Oroho, Esq.
Executive Vice President and, Chief Strategy Officer, Porzio Pharmaceutical Services, LLC; Principal, Porzio, Bromberg & Newman
Neena M. Patil, Esq.
Senior Corporate Counsel, Novo Nordisk Inc.
Lawrence P. Platkin
Vice President and Compliance Officer, Bayer Healthcare LLC
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP
Lynn Robson, Esq.
Executive Director, Legal and Compliance, LEO Pharma Inc.
Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals
Michael L. Shaw, Esq.
Vice President & Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals
Karen Patruno Sheehy, Esq.
Vice President, US Corporate Compliance Officer, Sanofi
Eric Siegel, Esq.
Executive Vice President & General Counsel, Incyte Corporation
Paul J. Silver
Managing Director, Huron Consulting Group
Jon Smollen
Executive Vice President and Chief Compliance Officer, Endo Pharmaceuticals Inc.
Don Soong
Vice President of Strategic Solutions, Cegedim Relationship Management, Richmond, VA
Jack T. Tanselle
Managing Director, Navigant Consulting, Inc.
Mike Wagner, Esq.
Partner and Chair, Global and North America Pharma Industry Groups, Baker & McKenzie
Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.
Ronald L. Wisor, Jr., Esq.
Partner, Hogan Lovells US LLP
Christopher D. Zalesky
Executive Director, World Wide Office of Health Care Compliance & Privacy, Johnson & Johnson
Richard L. Zimmerer
Partner, Forensic Advisory Services, KPMG LLP
|
|
PAST GLOBAL PHARMA CONGRESS CITIES
|
Washington, DC
Brussels
Paris
Rome
Berlin
Istanbul
Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
2013 - Madrid, Spain
|
|
FOLLOW PHARMA CONGRESS ON
|
|
|
 This site complies with the HONcode standard for trustworthy health information:
verify here.
|
|
|
SAVE THE DATES
|
|
THIRD ASIA PACIFIC
PHARMACEUTICAL COMPLIANCE
CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by Pharmaceutical Compliance Forum
September 10 - 12, 2013
Kuala Lampur, Malaysia
www.AsianPharmaCongress.com
|
|
FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 28 - 30, 2013
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com
|
|
SIXTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
|
A Hybrid Conference and Internet Event
February 5 - 7, 2014
Hyatt Regency Crystal City
Washington, DC
www.DisclosureSummit.com
|
|
|
|
